|
|
Wissenschaftliche Publikationen
Originalarbeiten in wissenschaftlichen
Fachzeitschriften:
- Adeberg S, Bernhardt D, Harrabi SB, Nicolay NH, Horner-Rieber J, Konig L, Repka M, Mohr A, Abdollahi A, Weber KJ, Debus J, Rieken S: Metformin Enhanced in Vitro Radiosensitivity Associates with G2/M Cell Cycle Arrest and Elevated Adenosine-5'-monophosphate-activated Protein Kinase Levels in Glioblastoma. Radiol Oncol, 2017; 51 (4): 431-437. : http://dx.doi.org/10.1515/raon-2017-0042
- Anagnostopoulos G, Andrassy M, Baltas D: The Bebig Valencia-type skin applicators: Dosimetric study and implementation of a dosimetric hybrid technique. Brachytherapy, 2017; 16 (5): 1044-1056. : http://dx.doi.org/10.1016/j.brachy.2017.04.243
- Aselmaa A, van Herk M, Laprie A, Nestle U, Gotz I, Wiedenmann N, Schimek-Jasch T, Picaud F, Syrykh C, Cagetti LV, Jolnerovski M, Song Y, Goossens RH: Using a contextualized sensemaking model for interaction design: A case study of tumor contouring. J Biomed Inform, 2017; 65: 145-158. : http://dx.doi.org/10.1016/j.jbi.2016.12.001
- Augustin NH, Kim SW, Uhlig A, Hanser C, Henke M, Schumacher M: A flexible multivariate random effects proportional odds model with application to adverse effects during radiation therapy. Biometrical J, 2017; 59: 1339-1351. : http://dx.doi.org/10.1002/bimj.201600142
- Balermpas P, Rodel F, Krause M, Linge A, Lohaus F, Baumann M, Tinhofer I, Budach V, Sak A, Stuschke M, Gkika E, Grosu AL, Abdollahi A, Debus J, Stangl S, Ganswindt U, Belka C, Pigorsch S, Multhoff G, Combs SE, Welz S, Zips D, Lim SY, Rodel C, Fokas E: The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Int J Cancer, 2017; 141 (3): 594-603. : http://dx.doi.org/10.1002/ijc.30770
- Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, Magliocco A, Bredel M, Robe P, Grosu AL, Stupp R, Curran W Jr, Becker AP, Salavaggione AL, Barnholtz-Sloan JS, Aldape K, Blumenthal DT, Brown PD, Glass J, Souhami L, Lee RJ, Brachman D, Flickinger J, Won M, Chakravarti A: Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525. Jama-j Am Med Assoc, 2017; 3 (6): 784-792. : http://dx.doi.org/10.1001/jamaoncol.2016.6020
- Bettinger D, Spode R, Glaser N, Buettner N, Boettler T, Neumann-Haefelin C, Brunner TB, Gkika E, Maruschke L, Thimme R, Schultheiss M: Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience. Bmc Gastroenterol, 2017; 17 (1) (online): 98-98. : http://dx.doi.org/10.1186/s12876-017-0656-z
- Bilger A, Frenzel O, Oehlke O, Schmucker M, Wiehle R, Milanovic D, Nieder C, Grosu AL: Local control and overall survival after frameless LINAC radiosurgery: a single center experience Neuro-oncology, 2017; 19 (3): 105-106.
- Carles M, Torres-Espallardo I, Alberich-Bayarri A, Olivas C, Bello P, Nestle U, Marti-Bonmati L: Evaluation of PET texture features with heterogeneous phantoms: complementarity and effect of motion and segmentation method. Phys Med Biol, 2017; 62 (2): 652-668. : http://dx.doi.org/10.1088/1361-6560/62/2/652
- Champ CE, Ohri N, Klement RJ, Cantor M, Beriwal S, Glaser SM, Smith RP: Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy. Clin Breast Cancer, 2017. : http://dx.doi.org/10.1016/j.clbc.2017.08.009
- Chatzikonstantinou G, Zamboglou N, Rodel C, Zoga E, Strouthos I, Butt SA, Tselis N: High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy : A systematic review. Strahlenther Onkol, 2017; 193 (9): 683-691. : http://dx.doi.org/10.1007/s00066-017-1157-2
- De Ruysscher D, Faivre-Finn C, Moeller D, Nestle U, Hurkmans CW, Le Pechoux C, Belderbos J, Guckenberger M, Senan S: European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol, 2017; 124 (1): 1-10. : http://dx.doi.org/10.1016/j.radonc.2017.06.003
- Fechter T, Adebahr S, Baltas D, Ben Ayed I, Desrosiers C, Dolz J: Esophagus segmentation in CT via 3D fully convolutional neural network and random walk. Med Phys, 2017; 44 (12): 6341-6352. : http://dx.doi.org/10.1002/mp.12593
- Fink MK, Klement RJ: Diazoxide for Lowering Insulin Levels in Breast Cancer Patients. Oncologist, 2017; 22 (4): 491-491. : http://dx.doi.org/10.1634/theoncologist.2016-0402
- Fricke A, Ullrich PV, Cimniak AFV, Becherer C, Follo M, Heinz J, Scholber J, Herget GW, Hauschild O, Wittel UA, Stark GB, Bannasch H, Braig D, Eisenhardt SU: Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism. Bmc Cancer, 2017; 17 (1) (online): 527. : http://dx.doi.org/10.1186/s12885-017-3515-y
- Galldiks N, Albert NL, Sommerauer M, Grosu AL, Ganswindt U, Law I, Preusser M, Rhun EL, Vogelbaum MA, Zadeh G, Dhermain F, Weller M, Langen KJ, Tonn JC: PET imaging in patients with meningioma-report of the RANO/PET Group. Neuro-oncology, 2017; 19 (12): 1576-1587. : http://dx.doi.org/10.1093/neuonc/nox112
- Gkika E, Adebahr S, Kirste S, Schimek-Jasch T, Wiehle R, Claus R, Wittel U, Nestle U, Baltas D, Grosu AL, Brunner TB: Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT. Strahlenther Onkol, 2017; 193 (6): 433-443. : http://dx.doi.org/10.1007/s00066-017-1099-8
- Gkika E, Beitinger E, Adebahr S, Schimek-Jasch T, Wiesemann S, Waller C, Grosu AL, Nestle U, Kayser G: Prognostic significance of different immunohistochemical markers in small cell lung cancer Ann Oncol, 2017; 28 Suppl. 2: mdx090.011. : https://doi.org/10.1093/annonc/mdx090.011
- Gkika E, Hallauer L, Kirste S, Adebahr S, Bartl N, Neeff HP, Fritsch R, Brass V, Nestle U, Grosu AL, Brunner TB: Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. Bmc Cancer, 2017; 17 (1): 781-781. : http://dx.doi.org/10.1186/s12885-017-3788-1
- Gkika E, Hallauer L, Kirste S, Adebahr S, Bartl N, Neeff HP, Fritsch R, Brass V, Nestle U, Grosu AL, Brunner TB: Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. Bmc Cancer, 2017; 17 (1): 781-781. : http://dx.doi.org/10.1186/s12885-017-3788-1
- Gkika E, Schultheiss M, Bettinger D, Maruschke L, Neeff HP, Schulenburg M, Adebahr S, Kirste S, Nestle U, Thimme R, Grosu AL, Brunner TB: Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma. Radiat Oncol, 2017; 12 (1) (online): 116-116. : http://dx.doi.org/10.1186/s13014-017-0851-7
- Gkika E, Tanadini-Lang S, Kirste S, Holzner PA, Neeff HP, Rischke HC, Reese T, Lohaus F, Duma MN, Dieckmann K, Semrau R, Stockinger M, Imhoff D, Kremers N, Hafner MF, Andratschke N, Nestle U, Grosu AL, Guckenberger M, Brunner TB: Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO). Strahlenther Onkol, 2017; 193 (10): 823-830. : http://dx.doi.org/10.1007/s00066-017-1177-y
- Gkika E, Vach W, Adebahr S, Schimeck-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Muller-Quernheim J, Grosu AL, Zissel G, Nestle U: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? Plos One, 2017; 12 (9) (online): e0185350. : http://dx.doi.org/10.1371/journal.pone.0185350
- Hatt M, Lee JA, Schmidtlein CR, Naqa IE, Caldwell C, De Bernardi E, Lu W, Das S, Geets X, Gregoire V, Jeraj R, MacManus MP, Mawlawi OR, Nestle U, Pugachev AB, Schoder H, Shepherd T, Spezi E, Visvikis D, Zaidi H, Kirov AS: Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211. Med Phys, 2017; 44 (6): e1-e42. : http://dx.doi.org/10.1002/mp.12124
- Jilg CA, Drendel V, Rischke HC, Beck T, Vach W, Schaal K, Wetterauer U, Schultze-Seemann W, Meyer PT: Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer. Theranostics, 2017; 7 (6): 1770-1780. : http://dx.doi.org/10.7150/thno.18421
- Klein Geltink RI, O'Sullivan D, Corrado M, Bremser A, Buck MD, Buescher JM, Firat E, Zhu X, Niedermann G, Caputa G, Kelly B, Warthorst U, Rensing-Ehl A, Kyle RL, Vandersarren L, Curtis JD, Patterson AE, Lawless S, Grzes K, Qiu J, Sanin DE, Kretz O, Huber TB, Janssens S, Lambrecht BN, Rambold AS, Pearce EJ, Pearce EL: Mitochondrial Priming by CD28. Cell, 2017; 171 (2): 385-397.e11. : http://dx.doi.org/10.1016/j.cell.2017.08.018
- Klement RJ, Guckenberger M, Alheid H, Allgauer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Habermehl D, Hildebrandt G, Lewitzki V, Ostheimer C, Papachristofilou A, Petersen C, Schneider T, Semrau R, Wachter S, Andratschke N: Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control. Radiother Oncol, 2017; 123 (2): 227-233. : http://dx.doi.org/10.1016/j.radonc.2017.01.013
- Linge A, Schotz U, Lock S, Lohaus F, von Neubeck C, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rodel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Lauber K, Pigorsch S, Combs SE, Monnich D, Zips D, Baretton GB, Buchholz F, Krause M, Belka C, Baumann M: Comparison of detection methods for HPV status as a prognostic marker for Radiother Oncol, 2017. : http://dx.doi.org/10.1016/j.radonc.2017.12.007
- MacManus M, Everitt S, Schimek-Jasch T, Li XA, Nestle U, Kong FS: Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization. Translational Lung Cancer Research, 2017; 6 (6): 670-688. : http://dx.doi.org/10.21037/tlcr.2017.09.05
- Mavroidis P, Komisopoulos G, Buckey C, Mavroeidi M, Swanson GP, Baltas D, Papanikolaou N, Stathakis S: Radiobiological evaluation of prostate cancer IMRT and conformal-RT plans using different treatment protocols. Phys Medica, 2017; 40: 33-41. : http://dx.doi.org/10.1016/j.ejmp.2017.07.003
- Moustakis C, Blanck O, Ebrahimi F, Ka Heng Chan M, Ernst I, Krieger T, Duma MN, Oechsner M, Ganswindt U, Heinz C, Alheit H, Blank H, Nestle U, Wiehle R, Kornhuber C, Ostheimer C, Petersen C, Pollul G, Baus W, Altenstein G, Beckers E, Jurianz K, Sterzing F, Kretschmer M, Seegenschmiedt H, Maass T, Droege S, Wolf U, Schoeffler J, Haverkamp U, Eich H, Guckenberger M: Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches. Strahlenther Onkol, 2017; 193 (12): 1068-1069. : http://dx.doi.org/10.1007/s00066-017-1216-8
- Moustakis C, Blanck O, Ebrahimi Tazehmahalleh F, Ka Heng Chan M, Ernst I, Krieger T, Duma MN, Oechsner M, Ganswindt U, Heinz C, Alheit H, Blank H, Nestle U, Wiehle R, Kornhuber C, Ostheimer C, Petersen C, Pollul G, Baus W, Altenstein G, Beckers E, Jurianz K, Sterzing F, Kretschmer M, Seegenschmiedt H, Maass T, Droege S, Wolf U, Schoeffler J, Haverkamp U, Eich HT, Guckenberger M: Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy. Strahlenther Onkol, 2017; 193 (10): 780-790. : http://dx.doi.org/10.1007/s00066-017-1151-8
- Nieder C, Hintz M, Oehlke O, Bilger A, Grosu AL: Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA). Radiat Oncol, 2017; 12 (1): 107-107. : http://dx.doi.org/10.1186/s13014-017-0844-6
- Nieder C, Hintz M, Oehlke O, Bilger A, Grosu AL: The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases. Clin Transl Oncol, 2017; 19 (9): 1141-1146. : http://dx.doi.org/10.1007/s12094-017-1651-0
- Nieder C, Norum J, Hintz M, Grosu AL: Short Survival Time after Palliative whole Brain Radiotherapy: Can We Predict Potential Overtreatment by Use of a Nomogram? J Cancer, 2017; 8 (9): 1525-1529. : http://dx.doi.org/10.7150/jca.18600
- Perry JR, Laperriere N, O'Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Back M, Tills M, Winch C, Baumert BG, Wick W, Ding K, Mason WP, Mulroy LA, NAZ F, Mathieu D, Vincent F, Kavan P, Masucci GL, Chung C, Macdonald DR, Pitz MW, Easaw J, Mckenzie M, Agranovich AL, Pai HH, Meijnder P, Bouttens F, Eekers D, Truc G, van den Bent MJ, Gijtenbeek J, Niel C, Kortmann R-D, Hanse M, Wiggenraad RGJ, Kantor G, Enting R, Steinbach J, Baurain j-F, Weytjens R, Reeni M, Bolla M, De Jong M, Fabbro M, Grosu A, Bozec L, Tabatabai G, Servagi-Vernat S, Chapman R, Dally M, Fay M, Foote M, Ludbrook J, Hill J, Potter A, Skala M, Joseph D, James M, Yamasaki F: Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. New Engl J Med, 2017; 376 (11): 1027-1037. : http://dx.doi.org/10.1056/NEJMoa1611977
- Ramkumar A, Stappers PJ, Niessen WJ, Adebahr S, Schimek-Jasch T, Nestle U/Song Y: Using GOMS and NASA-TLX to evaluate human-computer interaction process in interactive segmentation International Journal of Human-computer Interaction, 2017; 33 (2): 123-134.
- Rieber J, Abbassi-Senger N, Adebahr S, Andratschke N, Blanck O, Duma M, Eble MJ, Ernst I, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lohaus F, Lohr F, Petersen C, Schrade E, Streblow J, Uhlmann L, Wittig A, Sterzing F, Guckenberger M: Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease. Int J Radiat Oncol, 2017; 98 (3): 511-520. : http://dx.doi.org/10.1016/j.ijrobp.2016.09.026
- Schiller F, Fechter T, Zamboglou C, Chirindel A, Salman N, Jilg CA, Drendel V, Werner M, Meyer PT, Grosu AL, Mix M: Comparison of PET/CT and whole-mount histopathology sections of the human prostate: a new strategy for voxel-wise evaluation. EJNMMI Phys, 2017; 4 (1) (online): 21. : http://dx.doi.org/10.1186/s40658-017-0188-1
- Schlachter M, Fechter T, Adebahr S, Schimek-Jasch T, Nestle U, Buhler K: Visualization of 4D multimodal imaging data and its applications in radiotherapy planning. J Appl Clin Med Phys, 2017; 18 (6): 183-193. : http://dx.doi.org/10.1002/acm2.12209
- Strouthos I, Chatzikonstantinou G, Tselis N, Bon D, Karagiannis E, Zoga E, Ferentinos K, Maximenko J, Nikolettou-Fischer V, Zamboglou N: Photobiomodulation therapy for the management of radiation-induced dermatitis : A single-institution experience of adjuvant radiotherapy in breast cancer patients after breast conserving surgery. Strahlenther Onkol, 2017; 193 (6): 491-498. : http://dx.doi.org/10.1007/s00066-017-1117-x
- Tanadini-Lang S, Rieber J, Filippi AR, Fode MM, Streblow J, Adebahr S, Andratschke N, Blanck O, Boda-Heggemann J, Duma M, Eble MJ, Ernst I, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lohaus F, Petersen C, Schrade E, Wendt TG, Wittig A, Hoyer M, Ricardi U, Sterzing F, Guckenberger M: Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. Radiother Oncol, 2017; 123 (2): 182-188. : http://dx.doi.org/10.1016/j.radonc.2017.01.003
- Tselis N, Hoskin P, Baltas D, Strnad V, Zamboglou N, Rodel C, Chatzikonstantinou G: High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status. Clin Oncol-uk, 2017; 29 (7): 401-411. : http://dx.doi.org/10.1016/j.clon.2017.02.015
- Wieser G, Popp I, Christian Rischke H, Drendel V, Grosu AL, Bartholoma M, Weber WA, Mansi R, Wetterauer U, Schultze-Seemann W, Meyer PT, Jilg CA: Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT. Eur J Nucl Med Mol I, 2017; 44 (9): 1463-1472. : http://dx.doi.org/10.1007/s00259-017-3702-8
- Wilson JM, Mukherjee S, Brunner TB, Partridge M, Hawkins MA: Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy. Clin Oncol-uk, 2017; 29 (6): 370-377. : http://dx.doi.org/10.1016/j.clon.2017.01.038
- Zamboglou C, Drendel V, Jilg AC, Rischke HC, Beck TI, Schultze-Seemann W, Krauss T, Mix M, Schiller F, Wetterauer U, Werner M, Langer M, Bock M, Meyer PT, Grosu AL: Comparison of 68 Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology Theranostics, 2017; 7 (1): 228-237.
- Zamboglou C, Sachpazidis I, Koubar K, Drendel V, Wiehle R, Kirste S, Mix M, Schiller F, Mavroidis P, Meyer PT, Werner M, Grosu AL, Baltas D: Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology reference. Radiother Oncol, 2017; 123 (3): 472-477. : http://dx.doi.org/10.1016/j.radonc.2017.04.021
|
